Pituitary stalk interruption syndrome: genes and variants
Explore variant evidence for Pituitary stalk interruption syndrome across 2 analyzed proteins (DNMT1, SMARCA2). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 4 variants of uncertain significance and 1 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Pituitary stalk interruption syndrome
DNMT1: DNA (cytosine-5)-methyltransferase 1
It copies existing DNA methylation patterns during replication and also contributes to chromatin regulation and neuronal maintenance. Dominant pathogenic variants can cause hereditary sensory neuropathy with dementia and hearing loss or a cerebellar ataxia-deafness-narcolepsy syndrome.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DNMT1 have source records linked to Pituitary stalk interruption syndrome. Association strength is not clinical gene validity.
SMARCA2: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2
It provides ATP-dependent nucleosome remodeling activity to selected SWI/SNF complexes and helps control transcriptional access to chromatin. Heterozygous pathogenic variants cause Nicolaides-Baraitser syndrome or, through distinct mechanisms, blepharophimosis-intellectual-disability syndrome.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SMARCA2 have source records linked to Pituitary stalk interruption syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ARID1B, CHD7, FGFR3, PTCH1 and RAF1.
ClinVar pathogenic and likely pathogenic variants linked to Pituitary stalk interruption syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| DNMT1 D937G | 937 | Pathogenic / likely pathogenic (★) | |
| SMARCA2 S263T | 263 | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Intellectual disability - sparse hair - brachydactyly also has ClinVar records linked to SMARCA2 variants; they fall mostly in different places as the Pituitary stalk interruption syndrome variants (53 pathogenic / likely pathogenic).
- Blepharophimosis-impaired intellectual development syndrome also has ClinVar records linked to SMARCA2 variants; they fall mostly in different places as the Pituitary stalk interruption syndrome variants (8 pathogenic / likely pathogenic).
- Autosomal dominant cerebellar ataxia, deafness and narcolepsy also has ClinVar records linked to DNMT1 variants; they fall mostly in different places as the Pituitary stalk interruption syndrome variants (5 pathogenic / likely pathogenic).
- Hereditary sensory neuropathy-deafness-dementia syndrome also has ClinVar records linked to DNMT1 variants; they fall mostly in different places as the Pituitary stalk interruption syndrome variants (3 pathogenic / likely pathogenic).
Diseases related to Pituitary stalk interruption syndrome
- Intellectual disability - sparse hair - brachydactyly, also linked to SMARCA2
- Acute myeloid leukemia, also linked to DNMT1
- Blepharophimosis-impaired intellectual development syndrome, also linked to SMARCA2
- Spastic ataxia, also linked to DNMT1
- Autosomal dominant cerebellar ataxia, deafness and narcolepsy, also linked to DNMT1
- Hereditary sensory neuropathy-deafness-dementia syndrome, also linked to DNMT1
Frequently asked questions
Which genes have records linked to Pituitary stalk interruption syndrome?
This view contains 2 analyzed proteins: DNMT1, SMARCA2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 4 variants of uncertain significance and 1 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 7 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center